[Federal Register Volume 84, Number 171 (Wednesday, September 4, 2019)]
[Notices]
[Pages 46533-46534]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-19018]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-19-0852]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled Prevalence Survey of Healthcare-Associated 
Infections and Antimicrobial Use in U.S. Acute Care Hospitals to the 
Office of Management and Budget (OMB) for review and approval. CDC 
previously published a ``Proposed Data Collection Submitted for Public 
Comment and Recommendations'' notice on June 10, 2019 to obtain 
comments from the public and affected agencies. CDC did not receive 
comments related to the previous notice. This notice serves to allow an 
additional 30 days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.

[[Page 46534]]

    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Direct written comments 
and/or suggestions regarding the items contained in this notice to the 
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th 
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide 
written comments within 30 days of notice publication.

Proposed Project

    Prevalence Survey of Healthcare-Associated Infections and 
Antimicrobial Use in U.S. Acute Care Hospitals (OMB Control No. 0920-
0852, Exp. 12/31/2019)--Extension--National Center for Emerging and 
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    Preventing healthcare-associated infections (HAIs) and improving 
antimicrobial use (AU) are CDC and national priorities. An essential 
step in reducing the occurrence of HAIs is to estimate accurately the 
burden of these infections in U.S. acute care hospitals and to describe 
the types of HAIs and causative pathogens. Periodic assessments of the 
magnitude and types of HAIs and AU occurring in all patient populations 
within acute care hospitals are needed to inform decisions by policy 
makers and hospital infection control personnel (ICP) regarding 
appropriate targets and strategies for HAI prevention and antimicrobial 
stewardship.
    Since 2009, CDC has conducted four prevalence surveys (i.e., pilot 
survey in 2009, limited-scale survey in 2010, and two full-scale 
surveys in 2011 and 2015) in partnership with the CDC's Emerging 
Infections Program (EIP) sites. Findings from the most recent survey 
showed a reduction in the percentage of patients with healthcare-
associated infections compared with 2011.
    Minor adjustments to data collection instruments since the previous 
2016 OMB approval have been made. These adjustments were made to 
enhance future analyses and utility of the survey data. These changes 
are non-substantive and are not expected to increase the public 
reporting burden. An Extension of the prevalence survey's existing OMB 
approval is sought to allow a repeat HAI and AU Prevalence Survey to be 
performed in 2020. A repeat survey will allow assessment of changes in 
HAI and AU prevalence, pathogen distribution, and quality of 
antimicrobial prescribing. These data will also allow CDC and its 
partners to continue to monitor HAI and AU trends, to measure progress 
in meeting national targets, and to further refine prevention 
strategies.
    In the 2020 survey, data collection will occur within acute care 
general hospitals of varying size in each of the 10 EIP sites (i.e., 
CA, CO, CT, GA, MD, MN, NM, NY, OR, & TN). ICP in participating 
hospitals may assist EIP site personnel in collecting demographic and 
limited clinical data from the electronic or paper-based medical 
records of a sample of randomly selected patients on a single day in 
2020. Patients will not be interviewed, and no direct interaction with 
patients will occur. Hospital and patient-level data will be collected 
using unique identification codes. EIP site personnel will submit 
hospital and patient-level data to CDC using a secure data management 
system. Based on experiences from previous surveys, the time required 
to complete the Healthcare Facility Assessment Form (HFA) and Patient 
Information Form (PIF) is estimated to be 45 and 17 minutes, 
respectively. To conduct the full-scale survey in a three-year approval 
period, 100 hospital respondents will complete the HFA 1x and the PIF 
on average 63 x per year. The total estimated annualized public burden 
is 1,860 hours, which represents no change from the 2016 OMB approval.
    To assess changes in HAIs and AU over time, EIP sites will seek 
participation from the same hospitals that participated in prior 
surveys. These hospitals were originally selected for participation 
using a stratified random sampling scheme based on the number of 
staffed acute care beds (i.e., small: <150 staffed beds; medium: 151-
399 staffed beds; large: >400 staffed beds). Each site will also have 
the option to recruit additional hospitals for a total of up to 30 in 
each site. As in previous surveys, hospital participation will remain 
voluntary. Within each participating hospital, EIP site personnel will 
establish patient sample size targets based on the number of staffed 
acute care beds (e.g., up to 75 patients in small hospitals, 75 
patients in medium hospitals, and 100 patients in large hospitals). The 
estimated annual burden hours are 1860. There are no costs to 
respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
     Type of respondents           Form name         Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Hospital Staff (i.e.,         HFA *.............             100               1           45/60              75
 Infection Preventionist).
                              PIF **............             100              63           17/60            1785
----------------------------------------------------------------------------------------------------------------
* HFA: Healthcare Facility Assessment.
** PIF: Patient Information Form.


Jeffrey M. Zirger,
Acting Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2019-19018 Filed 9-3-19; 8:45 am]
 BILLING CODE 4163-18-P